Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03551938
Other study ID # FWA00004801
Secondary ID 5U19HD089881-04
Status Completed
Phase N/A
First received
Last updated
Start date June 28, 2018
Est. completion date August 20, 2021

Study information

Verified date May 2023
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We Prevent seeks to develop and pilot test a developmentally-appropriate relationship skills session as an addition to the current Couples HIV Testing and Counseling (CHTC) intervention for young gay, bisexual and other men who have sex with men (YMSM). This project involves three phases to develop and pilot test the intervention. Phase I collected brief quantitative survey data, in-depth qualitative interview data, and cognitive interview data from YMSM and feedback from a technical expert group (TEG) to develop and refine the two-session intervention. Phase II involved conducting a one-arm pilot of the intervention condition to further refine the intervention content with a sample of 12 YMSM (6 dyads). Phase III involves conducting a randomized controlled trial (RCT) comparing the relationship-focused intervention to a control condition, which is HIV Testing, Counseling, and Referrals (CTR) alone with a sample of 320 YMSM.


Description:

Young (15-24 years old) gay, bisexual and other men who have sex with men (YMSM) continue to be the group most heavily impacted by HIV in the US, despite stable or declining rates of infection among other groups. HIV prevention and research efforts in the US have continued to target MSM as individuals, largely focusing on messages that encourage the uptake of prevention efforts and reducing sexual risk. Recently, there has been growing interest in structural interventions to reduce HIV risk, tackling social, economic and cultural factors that place MSM in contexts of risk. However, despite socio-ecological theory postulating the importance of individual, dyadic and social influences on HIV risk, there has been a dearth of intervention efforts focused at the dyadic level. We Prevent seeks to intervene on relationship communication skills as a pathway to HIV prevention during the critical period of adolescence. The proposed activities will develop and test a relationship skills focused HIV prevention intervention for young YMSM aged 15-24 as an addition to the current HIV Counseling, Testing, and Referrals (CTR) and Couples HIV Testing and Counseling (CHTC). At home STI test kits will also be sent in Phases II and III at baseline and one follow up. Phase I of the project included collection of data from two groups of participants: 1) 30 YMSM in in-depth interviews and 8 YMSM in cognitive interviews and 2) 7 Technical Experts (TEG), for a total sample of 45 research participants. Phase II consisted of a one-arm pilot test of the intervention condition with 6 YMSM dyads (total 12 participants). Participants completed a Baseline and 1-month follow-up assessment. Phase III involves a pilot two-arm prospective RCT in which 320 YMSM will complete a Baseline assessment and then complete assessments every 3 months for 9 months. Recruitment of all participants is in all 50 states and will be conducted through popular social media sites (e.g. Facebook). All interviews will be conducted through the HIPAA video-conferencing platforms, VSee and Zoom. Specific Aims: Phases I and II: To develop and refine a developmentally appropriate relationship skills session as an addition to the current CHTC intervention for 15-19 year old YMSM and their partners. Phase III: To conduct a randomized controlled trial (RCT) comparing the efficacy of the adapted intervention for 15-24 year old YMSM versus a control condition, which is CTR or CHTC alone.


Recruitment information / eligibility

Status Completed
Enrollment 318
Est. completion date August 20, 2021
Est. primary completion date July 13, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years to 24 Years
Eligibility Inclusion Criteria: - Ages 15 to 24 years (inclusive) at time of screening - Current U.S. resident - Sufficient age for sexual consent in the current state of residence (assessed at both the individual and dyadic level) - Self-identify that they are in an emotional and sexual relationship with another male - Cisgender men (assigned male sex at birth and currently identifies as male) OR transgender men (assigned female at birth and identifies as male or transgender man - Self-reports that they engaged in any kind of sexual activity (oral, vaginal, anal) in their lifetime - Has access to computer/personal device/smart phone with internet access - Self-report being HIV negative or unknown serostatus - Speak and read English Exclusion Criteria: - Younger than age for consent without parental permission in the current state of residence - Assigned female sex at birth and currently identifies as something other than male or transgender man - Assigned male sex at birth but identifies as gender other than male or transgender man - Aged 14 years or younger or 25 or older at the time of screening - HIV-positive - Not currently in an emotional and/or sexual relationship with another male - Does not speak or read English - Reports intimate partner violence in the past 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Relationship skills session for YMSM partnered-individuals and couples
Relationship skills session as an addition to the current CTR and CHTC intervention for 15-24 year old YMSM and their partners.

Locations

Country Name City State
United States Center for Sexuality and Health Disparities Ann Arbor Michigan

Sponsors (3)

Lead Sponsor Collaborator
University of Michigan Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sexual Risk Behavior Anal or vaginal intercourse without condoms or PrEP that occurs with a person of known positive or unknown serostatus during follow-up period. The number of participants who report sexual risk behavior at 3 months.
Primary Sexual Risk Behavior Anal or vaginal intercourse without condoms or PrEP that occurs with a person of known positive or unknown serostatus during follow-up period. The number of participants who report sexual risk behavior at 6 months.
Primary Sexual Risk Behavior Anal or vaginal intercourse without condoms or PrEP that occurs with a person of known positive or unknown serostatus during follow-up period. The number of participants who report sexual risk behavior at 9 months.
Secondary HIV Communication Participants completed the 9-item Couples Efficacy to Reduce HIV Threat scale .Participants responded to each item on 5-point Likert scale ranging from (1) strongly disagree to (5) strongly agree. The items were mean centered such that higher scores indicate that participants perceive that they can effectively communicate with their partner about HIV prevention strategies (range 1 to 5). Mean at 3 months
Secondary HIV Communication Participants completed the 9-item Couples Efficacy to Reduce HIV Threat scale. Participants responded to each item on 5-point Likert scale ranging from (1) strongly disagree to (5) strongly agree. The items were mean centered such that higher scores indicate that participants perceive that they can effectively communicate with their partner about HIV prevention strategies (range 1 to 5). Mean at 6 months
Secondary HIV Communication Participants completed the 9-item Couples Efficacy to Reduce HIV Threat scale. Participants responded to each item on 5-point Likert scale ranging from (1) strongly disagree to (5) strongly agree. The items were mean centered such that higher scores indicate that participants perceive that they can effectively communicate with their partner about HIV prevention strategies (range 1 to 5). Mean at 9 months
Secondary PrEP Use Current PrEP use, which a self-report measure of whether the participant is currently using PrEP (yes/no). The number of participants at 3 months
Secondary PrEP Use Current PrEP use, which a self-report measure of whether the participant is currently using PrEP (yes/no) The number of participants at 6 months
Secondary PrEP Use Current PrEP use, which a self-report measure of whether the participant is currently using PrEP (yes/no) The number of participants at 9 months
Secondary HIV Testing Self-reported HIV testing in the past 3 months The number of participants at 3-months
Secondary HIV Testing Self-reported HIV testing in the past 3 months The number of participants at 6 months
Secondary HIV Testing Self-reported HIV testing in the past 3 months The number of participants at 9 months
Secondary STI Testing Any self-reported STI testing in the past 3 months The number of participants at 3 months
Secondary STI Testing Any self-reported STI testing in the past 3 months The number of participants at 6 months
Secondary STI Testing Any self-reported STI testing in the past 3 months The number of participants at 9 months
See also
  Status Clinical Trial Phase
Completed NCT03413696 - Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
Completed NCT03289676 - Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV Phase 1
Completed NCT03215901 - Life Plans Intervention Study N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Active, not recruiting NCT04064567 - Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK N/A
Completed NCT04013295 - Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya N/A
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT03984136 - HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM N/A
Completed NCT02928900 - Patient Actor Training to Improve HIV Services for Adolescents in Kenya N/A
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT02797262 - Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System N/A
Completed NCT02376582 - Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS Phase 1
Completed NCT01957865 - Real-Time Antiretroviral Therapy Adherence Intervention in Uganda N/A
Terminated NCT01443923 - Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV Phase 4
Completed NCT01616940 - Minority AIDS Initiative Retention and Re-Engagement Project N/A
Completed NCT01910714 - Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth N/A
Completed NCT01084421 - A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos N/A
Completed NCT01596322 - International HIV Antiretroviral Adherence, Resistance and Survival N/A
Completed NCT03643705 - A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention N/A
Completed NCT03923231 - Pharmacokinetics of Atazanavir in Special Populations